{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Shen AS"],"funding":["National Cancer Institute","NCI NIH HHS","National Institutes of Health"],"pagination":["103838"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10922787"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["45"],"pubmed_abstract":["<h4>Introduction</h4>Photodynamic therapy (PDT) is a safe, non-mutagenic, and non-scarring treatment for actinic keratoses (AK).<h4>Background</h4>'Painless' photodynamic therapy (p-PDT) is a regimen for AK that employs simultaneous aminolevulinate incubation and blue light illumination. The efficacy of p-PDT resembles that of traditional PDT, but detailed mechanisms of action for p-PDT are not well understood.<h4>Methods</h4>To characterize the inflammatory effects of the p-PDT procedure 48 h following treatment and determine the association of inflammation with precancer burden, we performed a retrospective cohort study of 104 patients with AK of face or scalp treated with p-PDT between 2017 and 2019. Patients self-reported their side effects 48 h following p-PDT and took photographs of their face and scalp. Photographs were edited to define seven anatomic regions, and erythema was scored by four investigators.<h4>Results</h4>Ninety-eight patients provided photographs suitable for erythema evaluation. Most patients experienced 2 or more side effects and some pain 48 h post-procedure. Females experienced more pain (p = 0.01) and side effects (p = 0.002) compared to males. AK burden was positively associated with post p-PDT erythema response (p < 0.0001) at all sites, but particularly in the temples (p = 0.002) and supralabial area (p = 0.009).<h4>Discussion</h4>This study confirms a strong clinical inflammatory response after p-PDT. Severity of inflammation is positively associated with AK tumor burden, suggesting that post-treatment inflammation may be a pre-requisite for p-PDT efficacy. Interestingly, the results also identify certain gender-related differences in the severity of side effects experienced by patients post-PDT."],"journal":["Photodiagnosis and photodynamic therapy"],"pubmed_title":["Painless photodynamic therapy for facial actinic keratoses: A retrospective cohort study of the post-treatment inflammatory response."],"pmcid":["PMC10922787"],"funding_grant_id":["P01 CA084203","R01 CA204158"],"pubmed_authors":["Nowacki AS","Updyke A","Warren CB","Maytin EV","Shen AS","Heusinkveld LE"],"additional_accession":[]},"is_claimable":false,"name":"Painless photodynamic therapy for facial actinic keratoses: A retrospective cohort study of the post-treatment inflammatory response.","description":"<h4>Introduction</h4>Photodynamic therapy (PDT) is a safe, non-mutagenic, and non-scarring treatment for actinic keratoses (AK).<h4>Background</h4>'Painless' photodynamic therapy (p-PDT) is a regimen for AK that employs simultaneous aminolevulinate incubation and blue light illumination. The efficacy of p-PDT resembles that of traditional PDT, but detailed mechanisms of action for p-PDT are not well understood.<h4>Methods</h4>To characterize the inflammatory effects of the p-PDT procedure 48 h following treatment and determine the association of inflammation with precancer burden, we performed a retrospective cohort study of 104 patients with AK of face or scalp treated with p-PDT between 2017 and 2019. Patients self-reported their side effects 48 h following p-PDT and took photographs of their face and scalp. Photographs were edited to define seven anatomic regions, and erythema was scored by four investigators.<h4>Results</h4>Ninety-eight patients provided photographs suitable for erythema evaluation. Most patients experienced 2 or more side effects and some pain 48 h post-procedure. Females experienced more pain (p = 0.01) and side effects (p = 0.002) compared to males. AK burden was positively associated with post p-PDT erythema response (p < 0.0001) at all sites, but particularly in the temples (p = 0.002) and supralabial area (p = 0.009).<h4>Discussion</h4>This study confirms a strong clinical inflammatory response after p-PDT. Severity of inflammation is positively associated with AK tumor burden, suggesting that post-treatment inflammation may be a pre-requisite for p-PDT efficacy. Interestingly, the results also identify certain gender-related differences in the severity of side effects experienced by patients post-PDT.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Feb","modification":"2025-04-04T08:51:04.867Z","creation":"2025-04-04T08:51:04.867Z"},"accession":"S-EPMC10922787","cross_references":{"pubmed":["37844787"],"doi":["10.1016/j.pdpdt.2023.103838"]}}